Is Sex a Determinant of COVID-19 Infection? Truth or Myth?

作者: Leanne Groban , Hao Wang , Xuming Sun , Sarfaraz Ahmad , Carlos M. Ferrario

DOI: 10.1007/S11906-020-01073-X

关键词:

摘要: Angiotensin-converting enzyme 2 (ACE2), a specific high-affinity angiotensin II-hydrolytic enzyme, is the vector that facilitates cellular entry of SARS-CoV-1 and novel SARS-CoV-2 coronavirus. SARS-CoV-2, which crossed species barriers to infect humans, highly contagious associated with high lethality due multi-organ failure, mostly in older patients other co-morbidities. Accumulating clinical evidence demonstrates intensity infection its complications are more prominent men. It has been postulated potential functional modulation ACE2 by estrogen may explain sex difference morbidity mortality. We review here regarding role estrogenic hormones expression regulation, intent bringing forefront mechanisms differences COVID-19 outcomes, assist management COVID-19, uncover new therapeutic strategies.

参考文章(143)
Jian-gui He, Jun Liu, Li-chun Wang, Xin-xue Liao, Yi-ming Cai, Li-jun Wang, Hong Ma, Wu-tao Zeng, Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats Academic journal of the first medical college of PLA. ,vol. 25, pp. 481- 487 ,(2005)
Daniel Batlle, Anastasia Z Kalea, Apelin and ACE2 in cardiovascular disease. Current opinion in investigational drugs. ,vol. 11, pp. 273- 282 ,(2010)
Kewal K. Jain, Personalized Management of Cardiovascular Disorders Medical Principles and Practice. ,vol. 26, pp. 399- 414 ,(2017) , 10.1159/000481403
Slava Epelman, W.H. Wilson Tang, Stephen Y. Chen, Frederick Van Lente, Gary S. Francis, Subha Sen, Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. Journal of the American College of Cardiology. ,vol. 52, pp. 750- 754 ,(2008) , 10.1016/J.JACC.2008.02.088
Kimiaki Komukai, Seibu Mochizuki, Michihiro Yoshimura, Gender and the renin-angiotensin-aldosterone system. Fundamental & Clinical Pharmacology. ,vol. 24, pp. 687- 698 ,(2010) , 10.1111/J.1472-8206.2010.00854.X
P. L. M. Dalpiaz, A. Z. Lamas, I. F. Caliman, R. F. Ribeiro, G. R. Abreu, M. R. Moyses, T. U. Andrade, S. A. Gouvea, M. F. Alves, A. K. Carmona, N. S. Bissoli, Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats PLOS ONE. ,vol. 10, pp. e0127515- ,(2015) , 10.1371/JOURNAL.PONE.0127515
Rebecca A. Lew, Fiona J. Warner, Iresha Hanchapola, Michael A. Yarski, Jay Manohar, Louise M. Burrell, A. Ian Smith, Angiotensin‐converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor Experimental Physiology. ,vol. 93, pp. 685- 693 ,(2008) , 10.1113/EXPPHYSIOL.2007.040352
K. Bridget Brosnihan, Jeffrey B. Hodgin, Oliver Smithies, Nobuyo Maeda, Patricia Gallagher, Tissue‐specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor‐α knock‐out mice Experimental Physiology. ,vol. 93, pp. 658- 664 ,(2008) , 10.1113/EXPPHYSIOL.2007.041806
Nanette J. Tomicek, Jennifer L. Miller-Lee, J. Craig Hunter, Donna H. Korzick, Estrogen Receptor Beta Does Not Influence Ischemic Tolerance in the Aged Female Rat Heart Cardiovascular Therapeutics. ,vol. 31, pp. 32- 37 ,(2013) , 10.1111/J.1755-5922.2011.00288.X
K. Bridget Brosnihan, Ping Li, Detlev Ganten, Carlos M. Ferrario, Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 273, ,(1997) , 10.1152/AJPREGU.1997.273.6.R1908